Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
about
Risk management in dermatology: an analysis of data available from several British-based reporting systems.Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.Alefacept for the treatment of psoriasis and other dermatologic diseases.Paradoxical Side Effect Related With Anti-Tumor Necrosis Factor Alpha Treatment.Etanercept-induced lichenoid reaction pattern in psoriasis.
P2860
Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
@ast
Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
@en
type
label
Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
@ast
Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
@en
prefLabel
Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
@ast
Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
@en
P2093
P2860
P356
P1433
P1476
Cutaneous adverse events of biological therapy for psoriasis: review of the literature.
@en
P2093
A M Thielen
J-H Saurat
P2860
P304
P356
10.1159/000087013
P577
2005-01-01T00:00:00Z